Foundation Medicine, Novartis Partner for Clinical Trial Enrollment

Jun 11, 2012, 01:00 AM by Michael Croft

Foundation Medicine | Foundation Medicine and Novartis are partnering on cancer drug testing. Novartis plans to use Foundation's technology as part of its cancer trial enrollment process over the next three years, focusing on Phase 1 and 2 oncology clinical programs.

June 11, 2012 | Foundation Medicine and Novartis are partnering on cancer drug testing. Novartis plans to use Foundation's technology (see, "Laying the Foundation for Next-Gen Cancer Diagnostics") as part of its cancer trial enrollment process over the next three years, focusing on Phase 1 and 2 oncology clinical programs. The two groups began a pilot program 18 months ago that has generated "very interesting data." Foundation Medicine recently made its genomic profile for patients commercially available. Foundation Medicine Statement [PDF]